Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Endologix Inc. ELGXQ

Healthcare
Endologix Inc develops, manufacture, market, and sell innovative medical devices for the treatment of aortic disorders in the United States and internationally. The company only reporting segment that is focused on the development, manufacture, marketing, and sale of EVAR and EVAS products for the treatment of aortic disorders. It product Includes a variety of endovascular stent grafts for the... see more

Recent & Breaking News (OTCPK:ELGXQ)

Endologix Announces First Commercial Implant of ALTO Abdominal Stent Graft System Outside of United States

Business Wire September 2, 2020

Endologix Receives CE Mark for ALTO Abdominal Stent Graft System

Business Wire August 5, 2020

Endologix Announces First Commercial Implant of ALTO Abdominal Stent Graft System & Official Start of U.S. Commercial Release

Business Wire July 30, 2020

Endologix Enters into an Agreement with Deerfield Partners to Take the Company Private

Business Wire July 5, 2020

Sight Sciences Strengthens Its Leadership Team with Chief Operating Officer and General Counsel Hires

PR Newswire June 25, 2020

Endologix Announces Departure of CFO and Appointment of Interim CFO

Business Wire June 18, 2020

Endologix Issues Correction Notice for Ovation iX Abdominal Stent Graft System

Business Wire June 15, 2020

Endologix Announces Completion of Enrollment in the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix EndoVascular Aneurysm Sealing System

Business Wire May 11, 2020

Endologix Reports First Quarter 2020 Financial Results

Business Wire May 11, 2020

Endologix, Inc. to Announce First Quarter 2020 Financial Results on May 11, 2020

Business Wire May 1, 2020

Endologix Appoints Tim A. Benner as Chief Commercial Officer

Business Wire April 14, 2020

Endologix Announces Preliminary Financial Results for First Quarter 2020

Business Wire April 6, 2020

Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire March 30, 2020

Endologix Adds Jane E. Kiernan to its Board of Directors

Business Wire March 17, 2020

Endologix Receives FDA Approval for Alto Abdominal Stent Graft System

Business Wire March 16, 2020

Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Business Wire March 6, 2020

Endologix Announces Debt Restructuring Addressing 2020 Maturities

Business Wire February 24, 2020

Endologix Reports Fourth Quarter and Fiscal Year 2019 Financial Results

Business Wire February 19, 2020

Endologix, Inc. to Present at the SVB Leerink Global Healthcare Conference

Business Wire February 18, 2020

Endologix Announces Preliminary Financial Results and Conference Call for Fourth Quarter and Full-Year 2019

Business Wire February 6, 2020